RxDoctor Payments Data

Behrang Vessali

Physician Assistant · Los Angeles, CANPI 1194261073

Payments from drug & device makers

$5,089in general payments, 2019–2025

Across 170 payments — averaging $29.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$735
  • Pfizer$567
  • Novartis$390
  • Antares Pharma, Inc.$310
  • Baxter Healthcare$300
  • Myriad Genetic Laboratories, Inc.$260
  • plus $3K from 26 others

What the payments were for

  • Food & beverage$5,089100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,089 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron85$70,136
GemtesaVibegron26$29,447
Tadalafil36$8,012
Testosterone46$5,822
Tamsulosin Hcl254$3,623
Estradiol19$1,723
Silodosin22$1,525
Oxybutynin Chloride ErOxybutynin Chloride71$1,518
Testosterone Cypionate26$1,385
Bicalutamide33$1,155
Solifenacin Succinate26$1,117
Finasteride77$734
Imipramine Hcl20$536
Alfuzosin Hcl ErAlfuzosin Hcl33$535
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip23$308

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$185$70,13685 claims
Sumitomo Pharma America, Inc.Gemtesa$112$29,44726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →